mucus d NDC 51316-345

NDC codes

FDA NDC Directory

Product NDC (as listed)51316-345Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51316-0345Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51316-345-62	51316034562	4 BLISTER PACK in 1 CARTON (51316-345-62) / 6 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Apr 4, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): mucus d
Generic name (nonproprietary): guaifenesin, pseudoephedrine hydrochloride
Active ingredients: Guaifenesin — 1200 mg/1Pseudoephedrine hydrochloride — 120 mg/1
Dosage form: Tablet, Multilayer, Extended release
Route: Oral
Labeler: CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214407
Marketing start: Apr 4, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Decreased Respiratory Secretion Viscosity (Physiologic effect)Increased Respiratory Secretions (Physiologic effect)
Identifiers: Product ID 51316-345_258a2fda-4b1a-4601-a12e-dbbf4cb4f9c3SPL ID 258a2fda-4b1a-4601-a12e-dbbf4cb4f9c3SPL set ID c8026a56-4249-48de-b763-2d1c55731733RxCUI 1244675UNII 495W7451VQ, 6V9V2RYJ8N
Pharmacologic class: Expectorant; alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451316034562 followed by a unit qualifier and the quantity

Package 51316-0345-62. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 26, 2026.

Indications (excerpt from the label)

Uses • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive • temporarily relieves nasal congestion due to • common cold • hay fever • upper respiratory allergies • temporarily restores freer breathing through the nose • promotes nasal and/or sinus drainage • temporarily relieves sinus congestion and pressure

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)